Stephens Consulting, LLC Roivant Sciences Ltd. Transaction History
Stephens Consulting, LLC
- $422 Billion
- Q2 2025
A detailed history of Stephens Consulting, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Stephens Consulting, LLC holds 3 shares of ROIV stock, worth $34. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$34% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
345Shares Held
495MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$766 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$721 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$536 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$475 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$419 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.21B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...